A Phase 2, Open-label, Multicenter, Randomized Study of the Efficacy and Safety of R07198457 in Combination with Pembrolizumab Versus Pembrolizumab in Patients with Previously Untreated Advanced Melanoma

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date16/08/19 → 31/12/24

Keywords

  • Medical oncology
  • Melanoma
  • Clinical trial